C-terminal truncation of alpha-COP affects functioning of secretory organelles and calcium homeostasis in Hansenula polymorpha.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 329505)

Published in Eukaryot Cell on February 01, 2004

Authors

Maria B Chechenova1, Nina V Romanova, Alexander V Deev, Anna N Packeiser, Vladimir N Smirnov, Michael O Agaphonov, Michael D Ter-Avanesyan

Author Affiliations

1: Institute of Experimental Cardiology, Cardiology Research Center, 121552 Moscow, Russia.

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

Protein folding in the cell. Nature (1992) 19.60

The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys (1952) 9.50

Protein sorting by transport vesicles. Science (1996) 7.47

Coatomer is essential for retrieval of dilysine-tagged proteins to the endoplasmic reticulum. Cell (1994) 6.57

Yeast Saccharomyces cerevisiae selectable markers in pUC18 polylinkers. Yeast (1990) 5.00

New pUC-derived cloning vectors with different selectable markers and DNA replication origins. Gene (1991) 4.90

The yeast secretory pathway is perturbed by mutations in PMR1, a member of a Ca2+ ATPase family. Cell (1989) 4.19

A new type of coated vesicular carrier that appears not to contain clathrin: its possible role in protein transport within the Golgi stack. Cell (1986) 4.04

Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus. J Cell Biol (1994) 3.67

The yeast Ca(2+)-ATPase homologue, PMR1, is required for normal Golgi function and localizes in a novel Golgi-like distribution. Mol Biol Cell (1992) 3.35

Glycoprotein biosynthesis in yeast. FASEB J (1993) 3.03

The medial-Golgi ion pump Pmr1 supplies the yeast secretory pathway with Ca2+ and Mn2+ required for glycosylation, sorting, and endoplasmic reticulum-associated protein degradation. Mol Biol Cell (1998) 2.56

ER protein quality control and proteasome-mediated protein degradation. Semin Cell Dev Biol (1999) 2.55

Perturbation of cellular calcium induces secretion of luminal ER proteins. Cell (1989) 2.45

The debate about transport in the Golgi--two sides of the same coin? Cell (2000) 2.33

The involvement of calcium in transport of secretory proteins from the endoplasmic reticulum. Cell (1990) 2.30

Specific requirements for the ER to Golgi transport of GPI-anchored proteins in yeast. J Cell Sci (1997) 2.28

The Golgi-localization of yeast Emp47p depends on its di-lysine motif but is not affected by the ret1-1 mutation in alpha-COP. J Cell Biol (1995) 2.26

COPI-independent anterograde transport: cargo-selective ER to Golgi protein transport in yeast COPI mutants. J Cell Biol (1997) 2.16

Regulating the retention of T-cell receptor alpha chain variants within the endoplasmic reticulum: Ca(2+)-dependent association with BiP. J Cell Biol (1991) 1.93

Perturbation of cellular calcium blocks exit of secretory proteins from the rough endoplasmic reticulum. J Biol Chem (1990) 1.86

COP I domains required for coatomer integrity, and novel interactions with ARF and ARF-GAP. EMBO J (2000) 1.82

Misreading of termination codons in eukaryotes by natural nonsense suppressor tRNAs. Nucleic Acids Res (2001) 1.68

Depletion of cellular calcium accelerates protein degradation in the endoplasmic reticulum. J Biol Chem (1991) 1.49

Ca2+ transport in Saccharomyces cerevisiae. J Exp Biol (1994) 1.39

epsilon-COP is a structural component of coatomer that functions to stabilize alpha-COP. EMBO J (1998) 1.38

Traffic COPs of the early secretory pathway. Traffic (2000) 1.38

COPI in ER/Golgi and intra-Golgi transport: do yeast COPI mutants point the way? Biochim Biophys Acta (1998) 1.36

Organization of the Golgi apparatus. Curr Opin Cell Biol (2000) 1.27

Active recycling of yeast Golgi mannosyltransferase complexes through the endoplasmic reticulum. Proc Natl Acad Sci U S A (2000) 1.13

Strategies for the improvement of thrombolytic agents. Thromb Haemost (1991) 1.10

Organization of the yeast Golgi complex into at least four functionally distinct compartments. Mol Biol Cell (2000) 1.06

Plasmid reorganization during integrative transformation in Hansenula polymorpha. Yeast (1995) 1.03

Semi-quantitative analysis of cytokine gene expression in blood and cerebrospinal fluid cells by reverse transcriptase polymerase chain reaction. Res Exp Med (Berl) (1995) 1.00

Mutation of the homologue of GDP-mannose pyrophosphorylase alters cell wall structure, protein glycosylation and secretion in Hansenula polymorpha. Yeast (2001) 0.91

Identification of sequences responsible for transcriptional regulation of the strongly expressed methanol oxidase-encoding gene in Hansenula polymorpha. Gene (1994) 0.90

A novel autonomously replicating sequence (ARS) for multiple integration in the yeast Hansenula polymorpha DL-1. J Bacteriol (1996) 0.86

Vectors for rapid selection of integrants with different plasmid copy numbers in the yeast Hansenula polymorpha DL1. Yeast (1999) 0.83

A novel vacuolar protein encoded by SSU21 / MCD4 is involved in cell wall integrity in yeast. Yeast (1999) 0.83

Aggregation and retention of human urokinase type plasminogen activator in the yeast endoplasmic reticulum. BMC Mol Biol (2002) 0.82

A disruption-replacement approach for the targeted integration of foreign genes in Hansenula polymorpha. Yeast (1995) 0.80

Cloning and characterization of the Hansenula polymorpha homologue of the Saccharomyces cerevisiae PMR1 gene. Yeast (1998) 0.77

[A novel approach to isolation and functional characterization of genomic DNA from the methylotrophic yeast Hansenula polymorpha]. Mol Biol (Mosk) (2003) 0.77

Sequencing and functional analysis of the Hansenula polymorpha genomic fragment containing the YPT1 and PMI40 genes. Yeast (2002) 0.76

Articles by these authors

Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J Biol Chem (2003) 3.53

Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells (2003) 2.53

Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery. FASEB J (2008) 1.74

Nonsense suppression in yeast cells overproducing Sup35 (eRF3) is caused by its non-heritable amyloids. J Biol Chem (2004) 1.67

Increased expression of Hsp40 chaperones, transcriptional factors, and ribosomal protein Rpp0 can cure yeast prions. J Biol Chem (2002) 1.40

Appearance and propagation of polyglutamine-based amyloids in yeast: tyrosine residues enable polymer fragmentation. J Biol Chem (2008) 1.38

The role of the N-terminal oligopeptide repeats of the yeast Sup35 prion protein in propagation and transmission of prion variants. Genetics (2005) 1.19

Purification and analysis of prion and amyloid aggregates. Methods (2006) 1.11

Yeast polypeptide chain release factors eRF1 and eRF3 are involved in cytoskeleton organization and cell cycle regulation. Cell Motil Cytoskeleton (2002) 1.09

Chaperone effects on prion and nonprion aggregates. Prion (2007) 1.06

N-terminal region of Saccharomyces cerevisiae eRF3 is essential for the functioning of the eRF1/eRF3 complex beyond translation termination. BMC Mol Biol (2006) 1.04

Novel non-Mendelian determinant involved in the control of translation accuracy in Saccharomyces cerevisiae. Genetics (2002) 1.01

Mismatch repair-dependent mutagenesis in nondividing cells. Proc Natl Acad Sci U S A (2012) 0.98

Polyglutamine toxicity is controlled by prion composition and gene dosage in yeast. PLoS Genet (2012) 0.98

Interdependence of amyloid formation in yeast: implications for polyglutamine disorders and biological functions. Prion (2010) 0.98

The effects of amino acid composition of glutamine-rich domains on amyloid formation and fragmentation. PLoS One (2012) 0.89

Prion and nonprion amyloids: a comparison inspired by the yeast Sup35 protein. Prion (2007) 0.89

Amyloid-mediated sequestration of essential proteins contributes to mutant huntingtin toxicity in yeast. PLoS One (2012) 0.88

Polymorphonuclear blood leukocytes and restenosis after intracoronary implantation of drug-eluting stents. Can J Physiol Pharmacol (2009) 0.83

Molecular basis for transmission barrier and interference between closely related prion proteins in yeast. J Biol Chem (2011) 0.83

Aggregation and retention of human urokinase type plasminogen activator in the yeast endoplasmic reticulum. BMC Mol Biol (2002) 0.82

Could yeast prion domains originate from polyQ/N tracts? Prion (2013) 0.80

DNA aptamers detecting generic amyloid epitopes. Prion (2012) 0.80

Inactivation of Pmc1 vacuolar Ca(2+) ATPase causes G(2) cell cycle delay in Hansenula polymorpha. Cell Cycle (2012) 0.78

Elongation factor eEF1B modulates functions of the release factors eRF1 and eRF3 and the efficiency of translation termination in yeast. BMC Mol Biol (2009) 0.78

Circulating bone marrow stem/progenitor cells in vascular atherogenesis and in the noninvasive diagnosis of coronary stenosis. Exp Clin Cardiol (2005) 0.78

Functional and molecular characterization of novel Hansenula polymorpha genes, HpPMT5 and HpPMT6, encoding protein O-mannosyltransferases. Fungal Genet Biol (2013) 0.78

Circulating stromal osteonectin-positive progenitor cells and stenotic coronary atherosclerosis. Can J Physiol Pharmacol (2007) 0.77

Correct GPI-anchor synthesis is required for the incorporation of endoglucanase/glucanosyltransferase Bgl2p into the Saccharomyces cerevisiae cell wall. FEMS Microbiol Lett (2002) 0.77

Mutation of the protein-O-mannosyltransferase enhances secretion of the human urokinase-type plasminogen activator in Hansenula polymorpha. Yeast (2005) 0.76

Vascular endothelium: target or victim of cytostatic therapy? Can J Physiol Pharmacol (2007) 0.76

Sequencing and functional analysis of the Hansenula polymorpha genomic fragment containing the YPT1 and PMI40 genes. Yeast (2002) 0.76

Efficient library construction by in vivo recombination with a telomere-originated autonomously replicating sequence of Hansenula polymorpha. Appl Environ Microbiol (2003) 0.75

In-stent restenosis after revascularization of myocardium with drug-eluting stents is accompanied by elevated level of blood plasma eosinophil cationic protein. Can J Physiol Pharmacol (2011) 0.75

Detection of the centriole tyr- or acet-tubulin changes in endothelial cells treated with thrombin using microscopic immunocytochemistry. Cell Motil Cytoskeleton (2005) 0.75